Reference health

Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

https://doi.org/10.1016/j.jddst.2021.102535
CiteStamped reference-health badge
34/34 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

8 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 34 checked references that resolve
resolves10.1016/j.phrs.2009.05.007
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity
resolves10.1016/S0076-6879(05)91004-5
The Liposomal Formulation of Doxorubicin
resolves10.1016/j.jconrel.2012.03.020
Doxil® — The first FDA-approved nano-drug: Lessons learned
resolves10.2147/IJN.S123437
Nanomedicine applications in the treatment of breast cancer: current state of the art
resolves10.2147/IJN.S146315
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
resolves10.1038/nnano.2011.166
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
resolves10.1016/S0378-5173(97)00415-8
Pegylated liposomal doxorubicin (DOXIL®, CAELYX®) distribution in tumour models observed with confocal laser scanning microscopy
resolves10.1016/S0378-5173(96)04674-1
Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy
resolves10.1073/pnas.0611660104
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling
resolves10.1093/jnci/djj070
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
resolves10.1016/bs.enz.2018.07.005
Controlled Release With Emphasis on Ultrasound-Induced Release
resolves10.1021/acs.chemrev.5b00456
Gated Materials for On-Command Release of Guest Molecules
resolves10.1039/C7CS00219J
Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems
resolves10.1002/smll.201902242
New Advances in In Vivo Applications of Gated Mesoporous Silica as Drug Delivery Nanocarriers
resolves10.1016/j.colsurfb.2017.05.032
Folate/ N -acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study
resolves10.1039/c0nr00156b
Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challenges
resolves10.1016/j.jconrel.2018.08.024
Mesoporous silica nanoparticles as cutting-edge theranostics: Advancement from merely a carrier to tailor-made smart delivery platform
resolves10.1016/j.biopha.2018.10.167
Mesoporous silica nanoparticles for therapeutic/diagnostic applications
resolves10.1016/j.cej.2018.11.156
Mesoporous silica nanoparticles: Synthesis, pharmaceutical applications, biodistribution, and biosafety assessment
resolves10.1007/s13277-015-3706-6
Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy
resolves10.2147/IJN.S142668
Folic acid-conjugated mesoporous silica nanoparticles for enhanced therapeutic efficacy of topotecan in retina cancers
resolves10.1039/C8NJ05476B
Folate <b>-</b> targeting and bovine serum albumin-gated mesoporous silica nanoparticles as a redox-responsive carrier for epirubicin release
resolves10.1039/C5TB00587F
Folic acid-conjugated organically modified silica nanoparticles for enhanced targeted delivery in cancer cells and tumor in vivo
resolves10.1021/acsami.5b09483
Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum
resolves10.1021/acsbiomaterials.7b00972
Combination Loading of Doxorubicin and Resveratrol in Polymeric Micelles for Increased Loading Efficiency and Efficacy
resolves10.1016/j.msec.2018.04.047
One-pot green synthesis of doxorubicin loaded-silica nanoparticles for in vivo cancer therapy
resolves10.3390/ma13081998
Biphenyl Wrinkled Mesoporous Silica Nanoparticles for pH-Responsive Doxorubicin Drug Delivery
resolves10.1021/nn700040t
Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and Delivery
resolves10.1039/c3tb20544d
Polymeric mesoporous silica nanoparticles as a pH-responsive switch to control doxorubicin intracellular delivery
resolves10.1016/S0939-6411(97)00082-9
Comparative in vitro biocompatibility testing of polycyanoacrylates and poly(d,l-lactide-co-glycolide) using different mouse fibroblast (L929) biocompatibility test models
resolves10.1016/j.biomaterials.2008.02.020
Targeted delivery of paclitaxel using folate-decorated poly(lactide)–vitamin E TPGS nanoparticles
resolves10.1039/C5DT03700J
Ultra-small mesoporous silica nanoparticles as efficient carriers for pH responsive releases of anti-cancer drugs
resolves10.1016/j.molliq.2018.07.024
Preparation of folic acid-conjugated dendritic mesoporous silica nanoparticles for pH-controlled release and targeted delivery of a cyclometallated gold(III) complex as an antitumor agent
resolves10.18632/oncotarget.25470
Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action
The 8 references without a DOI — listed, not checked
no DOI — not checkedEpidemiological characteristics of and risk factors for breast cancer in the world
no DOI — not checkedA small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery
no DOI — not checkedMesoporous silica as carrier for drug-delivery systems
no DOI — not checkedCancer chemotherapy: targeting folic acid synthesis
no DOI — not checkedSynthesis of small-sized mesoporous silica nanoparticles by experimental design and characterization for further drug delivery
no DOI — not checkedDoxorubicin-loaded PLGA nanoparticles - a systematic evaluation of preparation techniques and parameters∗
no DOI — not checkedpH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment
no DOI — not checkedEtoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.jddst.2021.102535"><img src="https://citestamp.com/citestamped/10.1016/j.jddst.2021.102535/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.jddst.2021.102535/badge.svg)](https://citestamp.com/citestamped/10.1016/j.jddst.2021.102535)